July 16, 2024Open Access

Lifileucel: FDA-approved T-cell therapy for melanoma

Key Points

Key points are not available for this paper at this time.

Abstract

This commentary reports on the history of tumor-infiltrating lymphocytes (TIL) for adoptive cell therapy and where TIL fits into the treatment options for metastatic melanoma.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Kwong et al. (Tue,) studied this question.

www.synapsesocial.com/papers/68e6012eb6db643587594c6b — DOI: https://doi.org/10.1093/oncolo/oyae136

Authors

Mei Li M. Kwong

James C. Yang

Journals

The Oncologist

Actions

Institutions

National Cancer Institute

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Lifileucel: FDA-approved T-cell therapy for melanoma

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Also consider